{"id":"https://openalex.org/W2021759282","doi":"https://doi.org/10.1016/s1569-9056(09)60251-7","title":"246 OVERALL SURVIVAL WITH SUNITINIB VERSUS INTERFERON-ALFA (IFN-\u25a1) AS FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA (MRCC)","display_name":"246 OVERALL SURVIVAL WITH SUNITINIB VERSUS INTERFERON-ALFA (IFN-\u25a1) AS FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA (MRCC)","publication_year":2009,"publication_date":"2009-03-01","ids":{"openalex":"https://openalex.org/W2021759282","doi":"https://doi.org/10.1016/s1569-9056(09)60251-7","mag":"2021759282"},"language":"en","primary_location":{"id":"doi:10.1016/s1569-9056(09)60251-7","doi":"https://doi.org/10.1016/s1569-9056(09)60251-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1569-9056(09)60251-7","pdf_url":null,"source":{"id":"https://openalex.org/S59248909","display_name":"European Urology Supplements","issn_l":"1569-9056","issn":["1569-9056","1878-1500"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Urology Supplements","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049048398","display_name":"Cezary A. Szczylik","orcid":"https://orcid.org/0000-0002-2524-2810","observed_orcids":["https://orcid.org/0000-0002-2524-2810"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Szczylik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020353650","display_name":"Sylvie N\u00e9grier","orcid":"https://orcid.org/0000-0002-0984-8505","observed_orcids":["https://orcid.org/0000-0002-0984-8505"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Negrier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059690857","display_name":"St\u00e9phane Marie. Oudard","orcid":"https://orcid.org/0000-0003-0893-285X","observed_orcids":["https://orcid.org/0000-0003-0893-285X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Oudard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050649350","display_name":"Robert A. Figlin","orcid":"https://orcid.org/0000-0002-6323-6075","observed_orcids":["https://orcid.org/0000-0002-6323-6075"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R.A. Figlin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102785664","display_name":"Thomas E. Hutson","orcid":"https://orcid.org/0000-0002-4529-4212","observed_orcids":["https://orcid.org/0000-0002-4529-4212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T.E. Hutson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082009347","display_name":"Piotr Tomczak","orcid":"https://orcid.org/0000-0002-8816-5525","observed_orcids":["https://orcid.org/0000-0002-8816-5525"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Tomczak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028789952","display_name":"Marc Dror Michaelson","orcid":"https://orcid.org/0000-0001-9249-6338","observed_orcids":["https://orcid.org/0000-0001-9249-6338"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.D. Michaelson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112418138","display_name":"Ronald M. Bukowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R.M. Bukowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086392545","display_name":"Xinyan Huang","orcid":"https://orcid.org/0009-0005-7415-1914","observed_orcids":["https://orcid.org/0009-0005-7415-1914","https://orcid.org/0000-0002-6643-793X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"X. Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016738399","display_name":"S.T. Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.T. Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028836224","display_name":"I. Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5059063118","display_name":"Robert John Motzer","orcid":"https://orcid.org/0000-0001-6925-2327","observed_orcids":["https://orcid.org/0000-0001-6925-2327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R.J. Motzer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"4","first_page":"182","last_page":"182"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.921999990940094},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9610000252723694},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9449999928474426},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.972366988658905},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.9001806378364563},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.8424328565597534},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.6868266463279724},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6302899122238159},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5860134363174438},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4328128695487976},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.3526521325111389},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14570719003677368}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1569-9056(09)60251-7","doi":"https://doi.org/10.1016/s1569-9056(09)60251-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1569-9056(09)60251-7","pdf_url":null,"source":{"id":"https://openalex.org/S59248909","display_name":"European Urology Supplements","issn_l":"1569-9056","issn":["1569-9056","1878-1500"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Urology Supplements","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2050488070","https://openalex.org/W1982778812","https://openalex.org/W2095375648","https://openalex.org/W1963816326","https://openalex.org/W2210929914","https://openalex.org/W3027283457","https://openalex.org/W1982048793","https://openalex.org/W2050272218","https://openalex.org/W2901789096","https://openalex.org/W2084609580"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}